KINGSPARTAN
Posted - 15 hours ago
$DRRX It must suck being a Long here. Knowing that nothing can propel the share price. Longs waiting on that milestone of 300 patient enrollment just to see the share price sinking, even with more than average volume. By the time anything comes to light, if it does, AI will have created Artificial Livers, making DUR-928 worthless, much like today, and that is a big IF it was approved. Hard to get out of quick sand.
StreetwiseReports
Posted - 20 hours ago
H.C. Wainwright reiterated its Buy rating and $32 price target on this California-based biopharma that's currently trading below $6. Key Catalyst for US Biopharma Stock on Track for Q4/23: https://ow.ly/yeTX50OKLi8 $DRRX #Biopharma #stocks #hepatitis #liverhealth
littlechj
Posted - 22 hours ago
$DRRX Dr. McClain’s new article at @GoHealio on Larsucosteral’s “promising efficacy signals.” Additionally, Dr. Sussman attended the Marcus Evans 32nd Evolution Summit in Boston, discussing key management tactics in Larsucosteral trial. Both news available through Durect’s Twitter account.
LeftyT
Posted - 1 day ago
$DRRX picked up a few at 5.68 and 5.72 on the algo dip. Weird price action here on a crazy algo day. Also added more $ALT at 3.985 Crazy stuff... but too cheap to ignore.
udupisek
Posted - 1 day ago
$DRRX Why is the management is so exuberant ? Why Dr.Sussman is giving a talk in Marcus Evans 32nd Evolution Summit, presenting his lecture on "how efficient their clinical trial was during the tough Covid period" ? .Now, Why they are ahead of plans on marketing & sales ? Why they are ahead on the preparation for the NDA application with FDA ?and so on. I see one simple reason. IMO, They are confidant & looking ahead for the a positive end data & pounce on that.. Hopefully that is the case here. If that happens guess where can the stock price be after FDA approval ? $44 as the analyst Kristen ( Cantor Fitzgerald) predicts. ?? https://www.may23.evolutionsummit.com/
ld4
Posted - 1 day ago
$DRRX We have seen a decent uptick in volume with the moves higher over the last two days. It’s something to watch over the next few sessions.
wellingtoncp
Posted - 1 day ago
$DRRX this after hour bullshit is hilarious
bnjhnsn
Posted - 2 days ago
$DRRX this is us
bigbulldaddy
Posted - 2 days ago
$DRRX Whelp family I know I have said this before but I am officially saying it again. I am officially done accumulating. Need to go after other stocks in this market. If 25000 shares doesn't get me there I think all of us will be a little let down. Time to attack some other opportunities to diversify. Thankfully I have a fat stack of 13500 shares of PLTR in the 8 range and 13500 shares of SOFI in the 5 range. They will help float my boat if this fails. If all three fail I will probably cry lol. Good luck family.
sawbone57
Posted - 2 days ago
$DRRX remember, the last “give away” of stock options to insiders was via an option purchase price of (RS adjusted) $8.70, a 50% bump from today’s price. The largest shareholder, Bleichroeder, owns 10+% of company at an average purchase price of $20, a 3.4x today’s price. What does that tell you the very most informed people who have the most to gain or lose believe about this company??
littlechj
Posted - 2 days ago
$DRRX From this point, many (particularly tutes) would want to get in or increase their shares. They want to accumulate at low prices. They will do anything trying to keep the price low. Do not help them by selling your shares cheap. If all longs keep their shares or set an artificially high sale price, they will have to pay higher. If all longs continue to buy at the current prices, and not selling, the price will go up quicker. Obviously, that’s only possible in the ideal scenario. But we longs can only hope for and encourage each other. The BIG pay day is not too far away. Good luck!
littlechj
Posted - 2 days ago
$DRRX No offering at this point. It would be foolish to do so, and the management is not a fool. Signing ex-US rights deal would solve funding problems. Offering after unblinding data in October and price jump would be fine. No funding is needed at this point, and as the trial is closing down, the expense will be greatly reduced. Good luck to all longs.
doubleyou2
Posted - 2 days ago
@bnjhnsn @OldManLogan $DRRX That still is one of the usual stuff with small biotech stocks. They (almost) always need additional funds.
Cooking costs money.
And no Cooking without breking some eggs.
The best to all longs.
OldManLogan
Posted - 2 days ago
$DRRX Honestly, mgmt would be smarter to do a small offering now rather than kill the momentum when they release results by doing an offering immediately after announcing the phase 2b data... I recall when Adma did their last equity issuance, the SP started to climb immediately afterwards because investors weren't waiting for the other shoe to drop anymore... Still a close watcher here... good luck to longs.
littlechj
Posted - 2 days ago
$DRRX I would echo what LeftyT speculated: The “force” in control is trying to keep the share price low so that they can accumulate more shares. They will not let it run until the Tutes have enough. No one knows how long the stock will remain at this level, but my guess is, it will be over soon. When the price action is not favorable to longs, there will always be doubts. The company has funds through Q1, 2024. They do not need to raise money now (they are not stupid). They are more likely to do an offering AFTER the data release (and the price jump). They might be able to partner for and sign an ex-US right deal before year end. So many possibilities and no one knows for sure but the share price after a successful data outcome, which is the KEY and has a high probability, should be north of $40 (MC of $1B, which is about 7.5x the current). The bottom line is, be patient and keep adding while you can. Do your own DD and make a wise decision. Good luck to all longs.
JoelGoesDigital
Posted - 2 days ago
$DRRX is in a nice channel i will have it on my 🚨.
LeftyT
Posted - 2 days ago
@NewBiesRock @LaGiostra $GILD also paid $405 M in cash to buy out UK based MiroBio even b4 the P1 trial was completed!!! So tell me how $DRRX would NOT be a target for them when it's only trading at $150 M and just completed enrollment of a pivotal trial??? SO undervalued it's sad.
tradingsideways
Posted - 2 days ago
$DRRX not worried about price action. 90 days
Each day is 1.111111% closer to unblinding.
LeftyT
Posted - 2 days ago
@tarnaby The Tute's algos are working OT to accumulate $DRRX shares w/out raising the price. Tute ownership is relatively low here and they are trying to accumulate before the big rush this fall. That is a real tough task given the low trading volume and float for this stock. ANY uptick in price is met w/ algo walls to cap the rise and programmed selling to drop the price back down. It's a classic "accumulate 2, give one back" slow walk algo. Patience is needed here, and will be greatly rewarded.
LeftyT
Posted - 2 days ago
$DRRX This mngt team is pumped up for a reason. Clinical trial heads have made comments to them, on public record, that they are amazed how many patients are leaving the hospital after a single treatment in less than 4 days. That replicates what they saw in the 2a trial and is giving them confidence that the pivotal 2b trial is indeed "on track". They are confident enough to start their FDA NDA filing discussions early and initiating early commercial launch planning in the US. Don't forget they already have Fast Track Designation!!!
tarnaby
Posted - 2 days ago
$DRRX Curious that they are keeping it around $5.50. The last offering price. More dilution before results? Thoughts..?
LeftyT
Posted - 2 days ago
@NewBiesRock @LaGiostra If I was the CEO at $GILD I'd be pulling the trigger on a buyout deal for $DRRX right now. Their tech is a perfect fit for GILD sales/support and would add zero opex to support HUGE sales gains down the road. $4 B would be a great "win-win" deal. If they only go w/ an ex-US partnering deal, then you have to look at $AZN or $NVS as having the best ROI options available to them.
tradingsideways
Posted - 3 days ago
$DRRX end of June 7$ July 8$ September $9 Then FOMO sets in 10-15?
Results binary.
DMONEY1337
Posted - 3 days ago
$DRRX Bunch of whinny babies on this board. They already announced completion would happen around this time. No one with a brain is surprised the stock didn't rip on the news. The move will come in time.
bibi1
Posted - 3 days ago
$DRRX You know SHIT and you hold a SHIT!!!
mark these words and note them!!!
They will scar you for LIFE till you die!!!!
sawbone57
Posted - 3 days ago
$DRRX Assuming AHFIRM is successful and leads to FDA approval ( BIG assumption, but one all of us holding have made). What’s a reasonable price? 300,000 pts worldwide. Guess 1/3 need second dose for 400,000 TAM doses. Cheapest imaginable cost per dose $5000. 5 million more shares (sold at $20 per) gets $100 million to commercialize and pay insiders. P/S of 1 (industry average 4). 50% market penetration (If AHFIRM hits Larsucosterol will not just be SOC but malpractice NOT TO USE!!)
That leads to a SP of $33! All of my assumptions are obscenely LOW. This exercise is just to demonstrate how silly current price is. And that’s ZERO VALUE for Saber technology, ZERO VALUE for additional indications and ZERO VALUE for our leading epigenetic regulation research and other molecules.
LeftyT
Posted - 3 days ago
$DRRX The machines are trying to take this lower, so they can accumulate more shares for the Tutes, but this price is so cheap I don't care about pinching pennies right now and I've added 600 sh already and going for more on this dip.
LaGiostra
Posted - 3 days ago
$DRRX timing is now clear. Price move today is not relevant. Options activity now guided.
FULLYINSURED
Posted - 3 days ago
$DRRX , A lotta of ifs
LeftyT
Posted - 3 days ago
$DRRX What kind of trading sorcery is this??? I've got another LO out at 5.50 that is only partially (10 shares) filled, and a buy at 5.43 shows up on L2 w/out my order getting filled. I must not have the right computer and broker... let's get with it Fidelity!